← Leaderboards
Marisa McGinley
Cleveland Clinic Lerner Com-Cwru
$2,484,284
Attributed
$2,484,284
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $652.9K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,209,310 · 1
AHRQ$274,974 · 1
By mechanism
R01$2,209,310 · 1
R21$274,974 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Lan Zhou$4,689,034
- Jagan Ayyappan Pillai$7,065,897
Others in their field
Other Rising Stars on “Design”
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Jeffrey Leintz · National Opinion Research Center$38,969,238
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$30,895,527
Research focus
DesignDirect CostsCost Effectiveness AnalysisCovid-19 PandemicDiagnosisAmericanAutomobile DrivingAcademyAdultCare CostsAffectCaregiver BurdenCaringCentral Nervous System Demyelinating DisorderChronicClinicClinical CareAdherenceClinic VisitsCommunitiesComprehensive Health CareCostCare DeliveryDisability
Grant awards (6)
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial$617,044
R01 · FY2025 · NR · contact PI
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial$510,900
R01 · FY2024 · NR · contact PI
A Decision Support Tool for the Discontinuation of Disease Modifying Therapies in Multiple Sclerosis$142,027
R21 · FY2024 · HS · contact PI
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial$512,276
R01 · FY2023 · NR · contact PI
A Decision Support Tool for the Discontinuation of Disease Modifying Therapies in Multiple Sclerosis$132,947
R21 · FY2023 · HS · contact PI
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial$569,090
R01 · FY2022 · NR · contact PI